Interestingly, hydroxychloroquine had previously been shown to rescue tight junction loss in human umbilical vein derived endothelial cells (HUVECs), mediated by tumour necrosis factor-α (TNFα) and preeclampsia sera treatments, in vitro [9]. Here, TNF is linked to preeclampsia.